Clinical trial
Pioglitazone Treatment in Polycystic Ovary Syndrome
NCT00145340 · Odense University Hospital, Other · Completed
Key facts
| NCT number | NCT00145340 |
|---|---|
| Title | Pioglitazone Treatment in Polycystic Ovary Syndrome |
| Official title | The Effect of PPARgamma Stimulation on Glucose Metabolism, Insulin Resistance, Growth Hormone and Cortisol on Women Suffering From Polycystic Ovary Syndrome |
| Lead sponsor | Odense University Hospital, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Polycystic Ovary Syndrome |
| Intervention type | Drug |
| Interventions | pioglitazone |
| Enrollment | 30 |
| Start date | Sep 1, 2002 |
| Primary completion | Jan 1, 2007 |
| Completion | Jan 1, 2007 |
| First posted | Sep 5, 2005 |
| Last update posted | Sep 26, 2008 |
| Countries | Denmark |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: